Best for
Mobile
How to buy Diurnal Group shares
Own Diurnal Group shares in just a few minutes.
Diurnal Group plc is a drug manufacturers-specialty & generic business based in the UK. Diurnal Group shares (DNL.LSE) are listed on the London Stock Exchange (LSE) and all prices are listed in pence sterling. Diurnal Group employs 29 staff and has a trailing 12-month revenue of around £6.3 million.
How to buy shares in Diurnal Group
- Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
- Open your account. You'll need your ID, bank details and national insurance number.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: DNL in this case.
- Research Diurnal Group shares. The platform should provide the latest information available.
- Buy your Diurnal Group shares. It's that simple.
Diurnal Group share price
Use our graph to track the performance of DNL stocks over time.Diurnal Group shares at a glance
Information last updated 2021-01-24.
| Latest market close | N/Ap |
|---|---|
| 52-week range | 19.9787p - 79.7648p |
| 50-day moving average | 54.0524p |
| 200-day moving average | 53.7236p |
| Wall St. target price | 220p |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | -19.7p |
Invest in Diurnal Group shares with 0% commission
Other fees may apply. Your capital is at risk.
- Unlimited trades, with no dealing charges or management fees
- If your trades get copied you can earn extra money
- Create an account today in a few minutes
Go to site
Capital at risk
Share dealing platform comparison
Table: sorted by promoted deals first
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Is it a good time to buy Diurnal Group stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Diurnal Group financials
| Revenue TTM | £6.3 million |
|---|---|
| Gross profit TTM | £5.6 million |
| Return on assets TTM | -21.85% |
| Return on equity TTM | -27.77% |
| Profit margin | -64.5% |
| Book value | 0.151p |
| Market capitalisation | £80.9 million |
TTM: trailing 12 months
Diurnal Group share dividends
We're not expecting Diurnal Group to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
Diurnal Group share price volatility
Over the last 12 months, Diurnal Group's shares have ranged in value from as little as 19.9787p up to 79.7648p. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while Diurnal Group's is 1.1374. This would suggest that Diurnal Group's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Win £500 to get your trading started
Subscribe to trending stock alerts for a chance to win
Diurnal Group overview
Diurnal Group plc operates as a specialty pharma company worldwide. The company develops hormone therapeutics for the treatment of chronic endocrine conditions, including congenital adrenal hyperplasia, adrenal insufficiency, hypogonadism, and hypothyroidism. The company offers Alkindi, a replacement therapy for paediatric adrenal insufficiency in Europe. It also develops Chronocort, which completed Phase III clinical trials targeting congenital adrenal hyperplasia and adrenal insufficiency. The company's early stage pipeline products comprise Native Oral Testosterone, a replacement treatment for patients suffering from hypogonadism; siRNA, a short interfering RNA oligonucleotide therapy for patients suffering from adrenocorticotropin-dependent Cushing's syndrome; and T3 modified, a modified-release preparation of T3 (levothyroxine) hormone for patients suffering from hypothyroidism. Diurnal Group plc was incorporated in 2015 and is headquartered in Cardiff, the United Kingdom.
Frequently asked questions
More guides on Finder
-
How to buy Diurnal Group shares
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Charlie’s Holdings shares
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Lemonade shares
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Unity Software shares
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
-
How to buy FuelCell Energy shares
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Diurnal Group shares
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
-
How to buy Zomedica Pharmaceuticals shares
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
-
How to buy YRC Worldwide shares
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
-
How to buy Xeros Technology Group shares
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
-
How to buy Xpediator shares
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.
Ask an Expert